Agilon Health Q2 EPS $(0.04) Misses $(0.02) Estimate, Sales $1.15B Beat $1.11B Estimate
Portfolio Pulse from Benzinga Newsdesk
Agilon Health (NYSE:AGL) reported Q2 losses of $(0.04) per share, missing the analyst consensus estimate of $(0.02) by 100 percent. However, the company's quarterly sales of $1.15 billion beat the estimate of $1.11 billion by 3.51 percent, marking a 71.61 percent increase from the same period last year.
August 04, 2023 | 2:20 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Agilon Health's Q2 earnings per share missed estimates by 100%, but sales exceeded expectations by 3.51% and increased 71.61% YoY.
Agilon Health's stock may experience mixed reactions due to the missed EPS estimate, which is a negative signal. However, the significant increase in sales, which also beat estimates, could offset this negative impact and provide a positive signal to investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100